NCT02648854View on ClinicalTrials.gov

Investigate the Effect of Food on the Pharmacokinetic Characteristics of CKD-395 in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

October 31, 2015

Study Completion Date

November 30, 2015

Conditions
Diabetes Mellitus, Type II
Interventions
DRUG

CKD-395 0.5(Lobeglitazone)/1000(Metformin)mg 1T

administered CKD-395 0.5/1000mg 1T to oral (fasting condition)

DRUG

CKD-395 0.5(Lobeglitazone)/1000(Metformin)mg 1T

administered CKD-395 0.5/1000mg 1T to oral (High fat meal fed condition)

Trial Locations (1)

561-712

Chonbuk National University Hospital, Deokjin-gu

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY

NCT02648854 - Investigate the Effect of Food on the Pharmacokinetic Characteristics of CKD-395 in Healthy Male Volunteers | Biotech Hunter | Biotech Hunter